Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
63
days
Usability and Acceptance of Autoinjector and Prefilled Syringe Devices by Patients with Generalized Myasthenia Gravis in a Human Factors Study
Authors
Kelly G. Gwathmey; Panru Jing; Scott Laorr; Joe Koo; Sanjay Rakhade; Emmett Alton Sartor; J. T. Tibung; Jason Murray; Christina LaskarShow moreShow less
Affiliations
1. VCU Health, Virginia Commonwealth University, Richmond, USA; 2. Insight by Nemera, Chicago, USA; 3. Alexion, AstraZeneca Rare Disease, Boston, USA; 4. AstraZeneca, Boston, USA; 5. Alexion, AstraZeneca Rare Disease, Zurich, SwitzerlandShow moreShow less
120
days
Matching-Adjusted Indirect Comparison of Tarlatamab for Patients with Platinum-Refractory or Platinum-Resistant Extensive-Stage Small-Cell Lung Cancer
Authors
Franziska Dirnberger; Sachin Patel; Devon J. Boyne; Zhiyi Lan; Jenny Uyei; Jessie Wang; Seoyoon Cho; Lucy DeCosta; Ian M. Bridges; Umit TapanShow moreShow less
Affiliations
1. Amgen GmbH, Munich, Germany; 2. Amgen Ltd, Uxbridge, UK; 3. IQVIA Inc., Kirkland, Canada; 4. IQVIA Inc., San Mateo, USA; 5. Amgen Inc, Thousand Oaks, USA; 6. Section of Hematology and Medical Oncology, Boston University Chobanian & Avedisian School of Medicine, and Boston Medical Center, Boston, USAShow moreShow less
137
days
Management of Persistent Storage Symptoms and Overactive Bladder in Men Diagnosed with Benign Prostatic Hyperplasia: A Narrative Review
Authors
Bradley C. Gill; Matt T. Rosenberg; Steven A. Kaplan; Lori B. LernerShow moreShow less
Affiliations
1. Lerner College of Medicine, Cleveland Clinic, Cleveland, USA; 2. Department of Urology, Cleveland Clinic, Cleveland, USA; 3. Mid-Michigan Health Centers, Jackson, USA; 4. Department of Urology, Icahn School of Medicine at Mount Sinai, New York, USA; 5. VA Boston Healthcare System, Boston, USAShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days